Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTMX
FechaHoraFuenteTítuloSímboloCompañía
24/02/202115:15GlobeNewswire Inc.CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
22/02/202107:00GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming March Virtual Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
19/02/202107:00GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantNASDAQ:CTMXCytomX Therapeutics Inc
17/02/202107:00GlobeNewswire Inc.CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021NASDAQ:CTMXCytomX Therapeutics Inc
11/02/202116:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
04/02/202107:00GlobeNewswire Inc.CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology DayNASDAQ:CTMXCytomX Therapeutics Inc
03/02/202107:18GlobeNewswire Inc.UPDATE - CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CTMXCytomX Therapeutics Inc
03/02/202107:00GlobeNewswire Inc.CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CTMXCytomX Therapeutics Inc
29/01/202115:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTMXCytomX Therapeutics Inc
26/01/202107:00GlobeNewswire Inc.CytomX Therapeutics Announces Closing of Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
21/01/202116:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CTMXCytomX Therapeutics Inc
20/01/202120:50GlobeNewswire Inc.CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
19/01/202115:35GlobeNewswire Inc.CytomX Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CTMXCytomX Therapeutics Inc
19/01/202107:00GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantsNASDAQ:CTMXCytomX Therapeutics Inc
07/01/202107:00GlobeNewswire Inc.CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
28/12/202016:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
22/12/202015:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
22/12/202015:05GlobeNewswire Inc.CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
18/12/202015:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
03/12/202007:00GlobeNewswire Inc.CytomX Therapeutics to Present Updates on CX-2009 at 2020 San Antonio Breast Cancer SymposiumNASDAQ:CTMXCytomX Therapeutics Inc
11/11/202015:01GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
05/11/202015:15GlobeNewswire Inc.CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
05/11/202015:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
05/11/202007:00GlobeNewswire Inc.CytomX Therapeutics Announces Treatment of First Patient in Phase 2 Expansion Study of CX-2029, an Anti-CD71 Probody Drug Con...NASDAQ:CTMXCytomX Therapeutics Inc
29/10/202007:00GlobeNewswire Inc.CytomX Therapeutics to Announce Third Quarter 2020 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
06/10/202015:10GlobeNewswire Inc.CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D.NASDAQ:CTMXCytomX Therapeutics Inc
02/09/202007:00GlobeNewswire Inc.CytomX Therapeutics to Participate in Upcoming Healthcare ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
06/08/202015:15GlobeNewswire Inc.CytomX Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
04/08/202007:00GlobeNewswire Inc.CytomX Therapeutics to Participate in the 2020 Wedbush PacGrow Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
28/07/202007:00GlobeNewswire Inc.CytomX Therapeutics to Announce Second Quarter 2020 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX